StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.01−1.16 (-1.47%)

Close on Nov 17, 2026Market cap $1.92BP/E –Yield 2.19%

Innospec cash

Cash and short-term investments held at the end of each period.

Innospec's cash was $250.20M at Jun 30, 2026. For fiscal 2025 it was $292.50M, up 1.1% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $292.50M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$292.50M+1.1%
FY2024Dec 31, 2024$289.20M+42.0%
FY2023Dec 31, 2023$203.70M+38.5%
FY2022Dec 31, 2022$147.10M+3.7%
FY2021Dec 31, 2021$141.80M+34.7%
FY2020Dec 31, 2020$105.30M+39.1%
FY2019Dec 31, 2019$75.70M-38.5%
FY2018Dec 31, 2018$123.10M+36.5%
FY2017Dec 31, 2017$90.20M-11.5%
FY2016Dec 31, 2016$101.90M-28.1%
FY2015Dec 31, 2015$141.70M+206.0%
FY2014Dec 31, 2014$46.30M-46.7%
FY2013Dec 31, 2013$86.80M+215.6%
FY2012Dec 31, 2012$27.50M-66.0%
FY2011Dec 31, 2011$81.00M-27.2%
FY2010Dec 31, 2010$111.30M+62.2%
FY2009Dec 31, 2009$68.60M+393.5%
FY2008Dec 31, 2008$13.90M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$250.20M-6.2%
Q1 FY2026Mar 31, 2026$289.10M-3.6%
Q4 FY2025Dec 31, 2025$292.50M+1.1%
Q3 FY2025Sep 30, 2025$270.80M-10.9%
Q2 FY2025Jun 30, 2025$266.60M+11.0%
Q1 FY2025Mar 31, 2025$299.80M+11.0%
Q4 FY2024Dec 31, 2024$289.20M+42.0%
Q3 FY2024Sep 30, 2024$303.80M+46.6%
Q2 FY2024Jun 30, 2024$240.20M+44.8%
Q1 FY2024Mar 31, 2024$270.10M+83.1%
Q4 FY2023Dec 31, 2023$203.70M+38.5%
Q3 FY2023Sep 30, 2023$207.20M+106.2%
Q2 FY2023Jun 30, 2023$165.90M+132.4%
Q1 FY2023Mar 31, 2023$147.50M+39.7%
Q4 FY2022Dec 31, 2022$147.10M+3.7%
Q3 FY2022Sep 30, 2022$100.50M+12.7%
Q2 FY2022Jun 30, 2022$71.40M-24.4%
Q1 FY2022Mar 31, 2022$105.60M-9.7%
Q4 FY2021Dec 31, 2021$141.80M+34.7%
Q3 FY2021Sep 30, 2021$89.20M+33.9%
Q2 FY2021Jun 30, 2021$94.40M+62.2%
Q1 FY2021Mar 31, 2021$117.00M+71.8%
Q4 FY2020Dec 31, 2020$105.30M+39.1%
Q3 FY2020Sep 30, 2020$66.60M-39.6%
Q2 FY2020Jun 30, 2020$58.20M-45.1%
Q1 FY2020Mar 31, 2020$68.10M-44.9%
Q4 FY2019Dec 31, 2019$75.70M-38.5%
Q3 FY2019Sep 30, 2019$110.30M+20.7%
Q2 FY2019Jun 30, 2019$106.10M+60.8%
Q1 FY2019Mar 31, 2019$123.50M+58.1%
Q4 FY2018Dec 31, 2018$123.10M+36.5%
Q3 FY2018Sep 30, 2018$91.40M+39.5%
Q2 FY2018Jun 30, 2018$66.00M+35.2%
Q1 FY2018Mar 31, 2018$78.10M+72.0%
Q4 FY2017Dec 31, 2017$90.20M-11.5%
Q3 FY2017Sep 30, 2017$65.50M-60.8%
Q2 FY2017Jun 30, 2017$48.80M–
Q1 FY2017Mar 31, 2017$45.40M–
Q4 FY2016Dec 31, 2016$101.90M–
Q3 FY2016Sep 30, 2016$167.10M–

More Innospec figures

See a number that looks wrong?